As of 2026-01-08, the Relative Valuation of Adaptive Biotechnologies Corp (ADPT) is (15.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.73 USD, the upside of Adaptive Biotechnologies Corp based on Relative Valuation is -195.4%.
The range of the Relative Valuation is (17.23) - (17.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.9x - 38.9x | 35.0x |
| Forward P/E multiples | 21.7x - 34.3x | 26.0x |
| Fair Price | (17.23) - (17.97) | (15.97) |
| Upside | -203.0% - -207.4% | -195.4% |
| Date | P/E |
| 2026-01-06 | -30.77 |
| 2026-01-05 | -30.89 |
| 2026-01-02 | -30.39 |
| 2025-12-31 | -31.02 |
| 2025-12-30 | -31.37 |
| 2025-12-29 | -31.81 |
| 2025-12-26 | -31.90 |
| 2025-12-24 | -31.86 |
| 2025-12-23 | -32.00 |
| 2025-12-22 | -33.26 |
| 2025-12-19 | -32.47 |
| 2025-12-18 | -31.52 |
| 2025-12-17 | -30.79 |
| 2025-12-16 | -30.43 |
| 2025-12-15 | -29.97 |
| 2025-12-12 | -29.49 |
| 2025-12-11 | -29.46 |
| 2025-12-10 | -30.07 |
| 2025-12-09 | -28.39 |
| 2025-12-08 | -28.56 |
| 2025-12-05 | -28.18 |
| 2025-12-04 | -33.35 |
| 2025-12-03 | -32.72 |
| 2025-12-02 | -35.70 |
| 2025-12-01 | -35.99 |
| 2025-11-28 | -37.56 |
| 2025-11-26 | -37.67 |
| 2025-11-25 | -38.82 |
| 2025-11-24 | -39.08 |
| 2025-11-21 | -35.55 |
| 2025-11-20 | -31.18 |
| 2025-11-19 | -28.94 |
| 2025-11-18 | -26.27 |
| 2025-11-17 | -26.19 |
| 2025-11-14 | -26.94 |
| 2025-11-13 | -27.01 |
| 2025-11-12 | -27.70 |
| 2025-11-11 | -27.76 |
| 2025-11-10 | -28.10 |
| 2025-11-07 | -28.25 |
| 2025-11-06 | -29.72 |
| 2025-11-05 | -33.60 |
| 2025-11-04 | -32.32 |
| 2025-11-03 | -33.12 |
| 2025-10-31 | -33.16 |
| 2025-10-30 | -32.30 |
| 2025-10-29 | -32.09 |
| 2025-10-28 | -32.28 |
| 2025-10-27 | -32.70 |
| 2025-10-24 | -32.90 |